Hipgnosis Songs Fund Limited NPV (USD) (SOND) Share Price


NOTE: This is based on 0 open tips for Hipgnosis Songs Fund Limited NPV (USD) (SOND)


Hipgnosis Songs Fund Limited NPV (USD) (SOND)
Latest Quote Price

127.00p

Hipgnosis Songs Fund Limited NPV (USD) (SOND)
Price Change (%)

0.00%


Latest Bid : 121.00p Latest Ask : 133.00p
High Today : 128.00p Low Today : 128.00p
This Years High : 134.00p This Years Low : 128.00p
Volume : 0 MKT Cap : £1535.43M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Hipgnosis Songs Fund Limited NPV (USD) (SOND) Overview

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premi's Premium segment of the Main Market.


You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Hipgnosis Songs Fund Limited NPV (USD) (SOND) Active Short Positions

Fund Manager Position Date
Marshall Wace LLP 0.52% 16/04/2024

See more short positions...


Latest Bid : 121.00p Latest Ask : 133.00p
High Today : 128.00p Low Today : 128.00p
This Years High : 134.00p This Years Low : 128.00p
Volume : 0 MKT Cap : £1535.43M

Hipgnosis Songs Fund Limited NPV (USD) Overview

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premi's Premium segment of the Main Market.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.